JP2022530042A5 - - Google Patents
Info
- Publication number
- JP2022530042A5 JP2022530042A5 JP2021562971A JP2021562971A JP2022530042A5 JP 2022530042 A5 JP2022530042 A5 JP 2022530042A5 JP 2021562971 A JP2021562971 A JP 2021562971A JP 2021562971 A JP2021562971 A JP 2021562971A JP 2022530042 A5 JP2022530042 A5 JP 2022530042A5
- Authority
- JP
- Japan
- Prior art keywords
- sustained
- release formulation
- formulation according
- item
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025060888A JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837978P | 2019-04-24 | 2019-04-24 | |
| US62/837,978 | 2019-04-24 | ||
| US201962947188P | 2019-12-12 | 2019-12-12 | |
| US201962947183P | 2019-12-12 | 2019-12-12 | |
| US62/947,183 | 2019-12-12 | ||
| US62/947,188 | 2019-12-12 | ||
| PCT/US2020/029733 WO2020219822A1 (en) | 2019-04-24 | 2020-04-24 | Compositions and methods for modulating complement activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060888A Division JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530042A JP2022530042A (ja) | 2022-06-27 |
| JP2022530042A5 true JP2022530042A5 (https=) | 2023-05-01 |
| JP7726791B2 JP7726791B2 (ja) | 2025-08-20 |
Family
ID=70977557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562971A Active JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
| JP2025060888A Pending JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060888A Pending JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220211799A1 (https=) |
| EP (1) | EP3958842A1 (https=) |
| JP (2) | JP7726791B2 (https=) |
| KR (1) | KR20220004039A (https=) |
| CN (1) | CN113710230A (https=) |
| AU (1) | AU2020261059A1 (https=) |
| BR (1) | BR112021017820A2 (https=) |
| CA (1) | CA3137895A1 (https=) |
| IL (1) | IL287079A (https=) |
| MX (1) | MX2021013010A (https=) |
| SG (1) | SG11202109837SA (https=) |
| TW (1) | TW202106290A (https=) |
| WO (1) | WO2020219822A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3973994A1 (en) | 2014-06-12 | 2022-03-30 | RA Pharmaceuticals, Inc. | Modulation of complement activity |
| US9937222B2 (en) | 2015-01-28 | 2018-04-10 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
| RU2733720C2 (ru) | 2015-12-16 | 2020-10-06 | Ра Фармасьютикалз, Инк. | Модуляторы активности комплемента |
| KR20190093196A (ko) | 2016-12-07 | 2019-08-08 | 라 파마슈티컬스 인코포레이티드 | 보체 활성의 조절인자 |
| EP3870221A1 (en) * | 2018-10-22 | 2021-09-01 | RA Pharmaceuticals, Inc. | Neurological disease treatment with zilucoplan |
| JP2022535411A (ja) | 2019-06-04 | 2022-08-08 | ラ ファーマシューティカルズ インコーポレイテッド | 補体阻害剤による炎症性疾患治療 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241139A (zh) * | 1996-12-20 | 2000-01-12 | 武田药品工业株式会社 | 生产缓释制剂的方法 |
| AU1705100A (en) | 1998-10-09 | 2000-05-01 | Musc Foundation For Research Development | Blocking factor b to treat complement-mediated immune disease |
| EP2266606B1 (en) | 2003-05-15 | 2014-09-10 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
| CN1289066C (zh) * | 2003-09-18 | 2006-12-13 | 中国人民解放军第二军医大学 | 胰高血糖素样肽－1缓释微球制剂及其用途 |
| CA2610502A1 (en) | 2005-03-29 | 2006-10-05 | Cardax Pharmaceuticals, Inc. | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| WO2006128006A1 (en) | 2005-05-26 | 2006-11-30 | The Regents Of The University Of Colorado | Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| AU2006341116C1 (en) | 2005-09-27 | 2013-05-23 | Efrat Biopolymers Ltd. | Gelling hydrophobic injectable polymer compositions |
| SG10201804008UA (en) | 2005-11-04 | 2018-06-28 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
| CN101341254A (zh) * | 2005-12-24 | 2009-01-07 | 蒂加斯克乳制品研究中心 | 反-10，顺-12十八碳二烯酸的生产方法 |
| US20090028832A1 (en) * | 2006-08-10 | 2009-01-29 | Chung Leland F | Compositions and methods for targeted tumor therapy |
| EP2073898A1 (en) | 2006-10-10 | 2009-07-01 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Complement inhibition for improved nerve regeneration |
| US7736860B2 (en) | 2006-11-09 | 2010-06-15 | Univeristy Of Massachusetts | Methods of identifying compounds for the treatment of sterile inflammation |
| US20100015139A1 (en) | 2008-07-10 | 2010-01-21 | Rekha Bansal | METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF |
| CA2680833A1 (en) | 2007-04-30 | 2008-11-13 | Alcon Research, Ltd. | Treatment of age-related macular degeneration using inhibitors of complement factor d |
| RU2473563C2 (ru) | 2007-06-07 | 2013-01-27 | Дженентек, Инк. | АНТИТЕЛА ПРОТИВ C3b И СПОСОБЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СВЯЗАННЫХ С КОМПЛЕМЕНТОМ НАРУШЕНИЙ |
| US20110142837A1 (en) | 2007-07-20 | 2011-06-16 | Trustees Of The University Of Pennsylvania | Method Of Treating Acute Respiratory Distress Syndrome |
| CN101835794A (zh) | 2007-10-27 | 2010-09-15 | 霍夫曼-拉罗奇有限公司 | 使用固相和溶液相组合技术的促胰岛素肽合成法 |
| US20110172126A1 (en) | 2008-09-03 | 2011-07-14 | Xenome Ltd | Libraries of peptide conjugates and methods for making them |
| US20100086596A1 (en) * | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for releasing an octreotide compound without an initial time lag |
| CA2742802C (en) | 2008-11-10 | 2019-11-26 | Alexion Pharmaceuticals, Inc. | Methods and compositions for treating complement-associated disorders |
| DK2488203T3 (en) | 2009-10-16 | 2017-03-13 | Omeros Corp | METHODS OF TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITION OF MASP-2 DEPENDENT COMPLEMENT ACTIVATION |
| US9358266B2 (en) | 2010-02-25 | 2016-06-07 | The Trustees Of The University Of Pennsylvania | Treatment of sepsis using complement inhibitors |
| EP2563359A1 (en) | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| TW201241008A (en) * | 2010-10-01 | 2012-10-16 | Alexion Pharma Inc | Polypeptides that bind to human complement component C5 |
| BR112013025917A2 (pt) | 2011-04-08 | 2016-12-20 | Omeros Corp | uso de um anticorpo masp-2 ou fragmento do mesmo que inibe ativação de complemento dependente de masp-2 |
| WO2012162215A1 (en) | 2011-05-20 | 2012-11-29 | The Trustees Of The University Of Pennsylvania | Promotion of fracture healing using complement inhibitors |
| WO2012174055A1 (en) | 2011-06-13 | 2012-12-20 | The Trustees Of The University Of Pennsylvania | Wound healing using complement inhibitors |
| US20130246083A1 (en) | 2012-03-16 | 2013-09-19 | Alexion Pharmaceuticals, Inc. | Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor |
| US9579360B2 (en) | 2012-06-20 | 2017-02-28 | The Trustees Of The University Of Pennsylvania | Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| US20130345257A1 (en) | 2012-06-26 | 2013-12-26 | The Regents Of The University Of California | Composition for lupus nephritis and methods of making and using the same |
| WO2014078622A1 (en) | 2012-11-15 | 2014-05-22 | The Brigham And Women's Hospital, Inc. | Method and system for diagnosing and treating preeclampsia |
| US20140234275A1 (en) | 2013-02-15 | 2014-08-21 | Jason Williams | Method for treating als via the increased production of factor h |
| WO2015103319A1 (en) * | 2013-12-31 | 2015-07-09 | Heron Therapeutics, Inc. | Polymer-based compositions for extended release of proteins |
| EP3973994A1 (en) | 2014-06-12 | 2022-03-30 | RA Pharmaceuticals, Inc. | Modulation of complement activity |
| EP3262410B1 (en) | 2015-02-27 | 2024-08-14 | The Johns Hopkins University | Assay to diagnose and treat disorders of the alternative pathway of complement activation |
| RU2733720C2 (ru) | 2015-12-16 | 2020-10-06 | Ра Фармасьютикалз, Инк. | Модуляторы активности комплемента |
| KR20190093196A (ko) | 2016-12-07 | 2019-08-08 | 라 파마슈티컬스 인코포레이티드 | 보체 활성의 조절인자 |
| TWI826364B (zh) * | 2017-04-03 | 2023-12-21 | 德商因夫萊亞斯有限公司 | 活性抑制劑於發炎性疾病之治療 |
-
2020
- 2020-04-24 SG SG11202109837S patent/SG11202109837SA/en unknown
- 2020-04-24 BR BR112021017820A patent/BR112021017820A2/pt not_active Application Discontinuation
- 2020-04-24 TW TW109113822A patent/TW202106290A/zh unknown
- 2020-04-24 JP JP2021562971A patent/JP7726791B2/ja active Active
- 2020-04-24 US US17/605,495 patent/US20220211799A1/en active Pending
- 2020-04-24 MX MX2021013010A patent/MX2021013010A/es unknown
- 2020-04-24 KR KR1020217034548A patent/KR20220004039A/ko not_active Withdrawn
- 2020-04-24 AU AU2020261059A patent/AU2020261059A1/en not_active Abandoned
- 2020-04-24 CN CN202080030772.3A patent/CN113710230A/zh active Pending
- 2020-04-24 WO PCT/US2020/029733 patent/WO2020219822A1/en not_active Ceased
- 2020-04-24 CA CA3137895A patent/CA3137895A1/en active Pending
- 2020-04-24 EP EP20730497.3A patent/EP3958842A1/en active Pending
-
2021
- 2021-10-07 IL IL287079A patent/IL287079A/en unknown
-
2025
- 2025-04-02 JP JP2025060888A patent/JP2025118607A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530042A5 (https=) | ||
| JP2025118607A5 (https=) | ||
| TWI241911B (en) | Sustained release ranolazine formulations | |
| Ungaro et al. | Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs | |
| CA2473200C (en) | Extended release compositions comprising as active compound venlafaxine hydrochloride | |
| US20080057129A1 (en) | Drug microparticles | |
| CN113018277B (zh) | 注射用缓释制剂及其制备方法 | |
| RU2016143365A (ru) | Рапамицин-содержащая композиция, вводимая путем ингаляции для лечения возрастных заболеваний | |
| MX2008016254A (es) | Uso de agonistas del receptor de adenosina a2a en el tratamiento de isquemia. | |
| CN110339166B (zh) | 一种利拉鲁肽多囊脂质体及其制备方法和应用 | |
| TW200812642A (en) | Compositions and methods for treating conditions of the nail unit | |
| JP2022009026A (ja) | 低ナトリウムポロキサマー１８８製剤および使用方法 | |
| FR2582511A1 (fr) | Systeme d'application endonasal | |
| JP3852621B2 (ja) | 血管内皮細胞機能改善剤 | |
| JP2024545887A (ja) | 安定した受容体アゴニストの医薬組成物、製造方法及びその応用 | |
| JP2022062153A (ja) | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 | |
| CN110464835A (zh) | 一种胰岛素柔性微粒及其制剂 | |
| WO2000050015A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine | |
| WO2014169725A1 (zh) | 一种艾塞那肽微球制剂、其制备方法及其应用 | |
| JP2022527276A5 (https=) | ||
| CN117205319B (zh) | Hc030031在制备预防或治疗百草枯中毒引起的肺损伤的药物中的应用 | |
| JP7854206B2 (ja) | 肺線維症の予防または治療用の薬学製剤 | |
| RU2712448C1 (ru) | Способ кардиопротекции ишемических и реперфузионных повреждений в остром периоде инфаркта миокарда | |
| CN108472333A (zh) | 组合 | |
| JP7518149B2 (ja) | 高濃度インスリン製剤 |